Evidence map›Paper›PMID 40434799›Full record

Observational studyAnnals of medicine2025

Comparison of clinical characteristics of neurogenic rosacea and erythematotelangiectatic rosacea: a cross-sectional observational study.

Tingwei Liu, Zhi Yin, Meng Tao, Xiaoqi Meng, Hui Zhong, Yang Xu, Xiulan Sun

Abstract readObservational StudyComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tingwei LiuDepartment of Dermatology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.ORCID 0009-0009-8500-2227
Zhi YinDepartment of Dermatology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Meng TaoDepartment of Dermatology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Xiaoqi MengDepartment of Dermatology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Hui ZhongState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
Yang XuDepartment of Dermatology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Xiulan SunDepartment of Pharmacology, Jiangsu Key Laboratory of Neurodegeneration, Nanjing Medical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt remains controversial whether neurogenic rosacea (NR) is a distinctive subtype of rosacea, and no study has been conducted on the Chinese population. We compared the clinical characteristics of patients with NR and erythematotelangiectatic rosacea (ETR) and explored whether NR can be considered a distinctive rosacea subtype. MATERIALS AND

methodsNineteen patients with NR and 73 with ETR were enrolled. A questionnaire survey combined with electronic medical records and VISIA

resultsThe patients in the NR group reported less facial pruritus (36.8%) and dry skin (31.6%) than those in the ETR group (

conclusionsThere were few differences between ETR and NR in the Chinese population, with the exception of dryness and itching, though there was only a small sample size of NR in this study. NR may be referred to as ETR in patients with refractory erythema.

Indexed as

RosaceaAdultAgedChinaCross-Sectional StudiesFemaleFlushingHumansMaleMiddle AgedPruritusSurveys and Questionnaireserythematotelangiectatic rosaceaneurogenic rosaceaneuropsychiatric disordersrefractory rosaceaRosacea

Identifiers

PMID40434799
PMCPMC12120856

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.